Events
Calendar of Events
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
1 event,As part of SAE’s leading PFS Series, the 2026 conference will once again bring together top experts, industry leaders, and innovators for a three-days of key insights and networking. The conference will feature a comprehensive pre-conference focus day dedicated to advancements in device design, followed by a dynamic two-day main conference featuring keynote plenaries, interactive panel discussions, and specialized topic streams covering the […] |
5 events,Returning for its second year and building on the momentum of an inaugural edition that drew 100+ senior attendees, the 2nd Neuroscience Innovation Partnering & Licensing Summit is engineered to facilitate multiple high-impact, in-person meetings without the distractions of a broader, less-focused setting. Deliberately timed as an exclusive touchpoint for neuroscience business leaders to reconnect between […] The 5th ADC Analytical Development Summit is the industry’s only dedicated technical forum focused exclusively on solving the analytical challenges unique to antibody–drug conjugate (ADC) development. Designed for analytical, bioanalytical, and CMC leaders, the summit brings together senior experts from across pharma and biotech to advance analytical rigor, deepen product understanding, and enable regulatory-ready ADC […] Peptide therapies are rapidly becoming a disruptive modality, led by Merck’s oral PCSK9 inhibitor and Johnson & Johnson’s IL23R, with the hope to develop best-in-class drugs with improved chemistry, formulation and clinical efficacy. To shine a light on the progress of this field, the highly anticipated 3rd Peptide-Based Therapeutics Summit returns to Boston as the industry’s only dedicated platform to turbocharge the next generation […] The GPCR field is experiencing a renaissance, driven by renewed investment, clinical progress, and next-generation technologies unlocking hundreds of previously untargeted receptors. Furthermore, we’ve recently seen Takeda and Iambic Therapeutics’ $1.7bn partnership to advance AI-driven small molecule programs, and Kainova Therapeutics securing $32m CAD to accelerate immuno-oncology and inflammation therapies, momentum in the GPCR space continues to build. The race is on to […] |
0 events,
|
0 events,
|
0 events,
|
||
|
0 events,
|
1 event,Patient engagement has shifted from a “nice to have” to a strategic necessity. With regulators expecting defensible evidence, executives demanding clear ROI, and funding under tighter scrutiny, every engagement initiative must show measurable value. Yet many organizations still struggle to demonstrate the true impact of their work. The 3rd Measuring Patient Engagement Summit is the […] |
0 events,
|
0 events,
|
0 events,
|
||
|
0 events,
|
1 event,Optimize Model Selection, Accelerate Timelines, Improve Predictivity of Toxicity Dates: May 12-14 | Location: Boston, MA Why Attend With nearly 90% of drug candidates failing in the clinic and one-third of those failures driven by safety preclinical toxicology has reached a critical inflection point. Traditional models are no longer sufficient to predict human risk, leading […] |
0 events,
|
0 events,
|
0 events,
|
||
1 event,New assets have entered clinic, whilst dozens more have been disclosed, and recent investments such as, T-Therapeutics’ $91M Series A extension to advance their bispecific towards the clinic and Anocca’s SEK 440M raise, pinpoint how funding and portfolio decisions have the power to define the trajectory of the TCR field. It is in this context that the 7th TCR-Based Therapies Summit returns to unite fellow biopharma experts in address shared […] |
3 events,Returning for its 8th year, LEAP HR: Life Sciences West brings together 100+ senior HR leaders from scaling and stabilizing biotech organizations to navigate volatility and drive measurable business impact. Across three days of high-impact sessions, including case studies, benchmarking, roundtables, and structured networking, attendees will gain practical strategies to build lean HR functions, retain […] Biopharma investment into the formulation, delivery, and commercialization of intranasal therapies is at an all-time high, and there has never been such an opportunistic time to pursue nasal delivery. Alongside the market projection for intranasal therapies being forecasted to reach $21.2 billion by 2032, 2025 breakthroughs included Atzumi being approved for migraine treatment, and Eli Lilly’s Baqsimi now being […] |
0 events,
|
0 events,
|
0 events,
|
||
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|